Juraj Adamik

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Postmenopausal Women

Squamous Cell Carcinoma

Top Venues

Cancer research

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Molecular cancer therapeutics

Cancer immunology research

University of Pittsburgh Cancer Institute

Duquesne University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pittsburgh Cancer Institute

United States

Postdoctoral Associate :: Hematology/Oncology

Education History

Duquesne University Aug 21 2007 - May 03 2013

United States

PHD :: Natural and Environmental Sciences

Publications

Paul V Munson, Juraj Adamik, Felix J Hartmann, Patricia M B Favaro, Daniel Ho, Sean C Bendall, Alexis J Combes, Matthew F Krummel, Karen Zhang, Robin Kate Kelley, Lisa H Butterfield
Polyunsaturated fatty acid-bound alpha-fetoprotein promotes immune suppression by altering human dendritic cell metabolism. Cancer research (2023)
Deena M Maurer, Juraj Adamik, Patricia M Santos, Jian Shi, Michael R Shurin, Joanne M Jeter, Walter J Storkus, Lisa H Butterfield
Dysregulated NF-κB-Dependent ICOSL Expression in Human Dendritic Cell Vaccines Impairs T-cell Responses in Patients with Melanoma. Cancer immunology research 8 (12) (2020)
Juraj Adamik, Sree H Pulugulla, Peng Zhang, Quanhong Sun, Konstantinos Lontos, David A Macar, Philip E Auron, Deborah L Galson
EZH2 Supports Osteoclast Differentiation and Bone Resorption Via Epigenetic and Cytoplasmic Targets. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 35 (1) (2019)
Subrata Kumar Pore, Eun-Ryeong Hahm, Su-Hyeong Kim, Krishna B Singh, Lea Nyiranshuti, Joseph D Latoche, Carolyn J Anderson, Juraj Adamik, Deborah L Galson, Kurt R Weiss, Rebecca J Watters, Boeun Lee, Prashant N Kumta, Shivendra V Singh
A Novel Sulforaphane-Regulated Gene Network in Suppression of Breast Cancer-Induced Osteolytic Bone Resorption. Molecular cancer therapeutics 19 (2) (2019)